Sunshine Nora: ABA001 injection clinical trial application accepted

date
21/01/2026
Sunshine Nuohuo announcement: Recently, the company and its wholly-owned subsidiary Beijing Alna Technology Co., Ltd. have received the "Acceptance Notice" issued by the National Medical Products Administration, the clinical trial application for the investigational project ABA001 injection has been accepted. ABA001 injection is intended to be applied for the indication of hypertension.